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have identified a numerical implementation error which affects
some of the results and conclusions of the paper ‘‘Does anisotropy
promote spatial uniformity of stent-delivered drug distribution in
arterial tissue?”. Most significantly, the conclusion that the convec-
tion dominated case results in the highest levels of uniformity is
replaced with the conclusion that the diffusion dominated case
in fact results in the highest levels of uniformity, followed by the
reaction dominated case and lastly by the convection dominated
case. The updated plots for the convection dominated case are pre-
sented below (Fig. 1) whilst the plots for the diffusion and reaction
dominated cases are not provided, since they are visibly very sim-
ilar to those of the original paper. However, we provide updated
numerical values (which quantify the uniformity and agreement
between the one-dimensional and three-dimensional models) in
Tables 1 and 2 for all three cases (convection dominated, diffusion
dominated, reaction dominated). While the newly tabulated
results for the diffusion and reaction dominated cases show some
change, these data represent differences between concentration
profiles that have visibly not changed greatly. These data are thus
only provided for the sake of completeness. Values referred to in
the text of the original paper should be regarded as updated by
the values of the tables presented here. The text of Sections 4.1.1
and 4.2.1 is replaced by the updated text below. The plots associ-
ated with Section 4.5 (varying strut thickness and separation) are
also affected and we provide below in Fig. 2 the updated plots
for the convection dominated case (diffusion dominated and reac-
tion dominated figures are visibly very similar to the original
paper). Finally, for the benefit of the reader, we provide a com-
pletely revised Section 5.4.1. Uniformity of the drug concentrations
4.1.1. Convection dominated system (updated)
From Fig. 1 (top) we observe that in the convection dominated
regime the P1 and P2 concentration profiles differ substantially
close to the lumen. These differences reduce with time, but even
after 24 h, there is still a noticeable difference between the two
profiles. This is backed up by Table 1, where P1  P2k k is 7:4% after
one hour, and reduces only slightly to 6:3% by 3 h where it stays
for the remainder of the 28 days studied. Looking more closely at
Fig. 1 (top), we see that the region over which P1 and P2 noticeably
differ extends one fifth of the way into the arterial wall. Beyond
this thickness, uniform profiles are observed within one hour. In
Fig. 1 (bottom) we also display tissue concentration profiles within
abluminal-facing (y–z plane) slices taken at three different thick-
nesses and at two different times. The particular (narrow) scale
has been chosen to emphasize the differences, and this highlights
the non-uniformity of the profiles, especially closest to the lumen.
The conclusion is that in this convection dominated system, non-
uniform profiles are observed close to the wall, but highly uniform
concentration profiles may still be achieved throughout the major-
ity of the arterial wall, because of the anisotropic nature of the
diffusivity.4.2. Comparison between three-dimensional and one-
dimensional models
4.2.1. Convection dominated system (updated)
In the convection dominated case we see poor agreement
between the one-dimensional and the three-dimensional models
(Fig. 1 (top)). This is evidenced by the P11D  P13D



 values in
Table 2. After one hour, P11D  P13D



 is 22:0% and drops only
slightly to 19:9% by hour 3. Thus in this convection dominated
case, the one-dimensional model poorly predicts the arterial wall
drug distribution.
Fig. 1. Updated results for convection dominated regime. This replaces Fig. 3. of the original paper.
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In this paper we have addressed the validity of two common
assumptions that are made in modeling the distribution of drug
in the arterial wall following stent-based delivery. Firstly, we have
derived two conditions which must be satisfied to allow us to rea-
sonably approximate the curved arterial wall geometry as a rectan-
gular geometry. These conditions depend on the ratio of the
arterial wall thickness to the arterial radius, the ratio of arterial
wall thickness to strut separation and the ratio of the radial diffu-
sion coefficient to the axial/circumferential diffusion coefficient.
This analysis validates the extensive use of this assumption in
the literature, at least for the range of parameter values considered
here. Secondly, by comparing drug transport and distribution pre-
dicted by an idealized three-dimensional model with that of a one-
dimensional model, we have been able to show that a one-dimen-
sional model is adequate in certain circumstances. Furthermore,
we have verified that the anisotropic nature of diffusivity in the
arterial wall enhances the agreement between the one-dimen-
sional and three-dimensional models.We have analyzed three distinct regimes within the range of
typical parameter values considered. For the diffusion dominated
system, near-uniform profiles are achieved, although the influence
of the strut geometry is transmitted a small distance into the arte-
rial wall. When drug absorption is the significant feature, as in the
reaction dominated case, the influence of the strut geometry is even
more evident. The reason for this lies in the fact that high drug
absorption rates reduce the transport of drug through the arterial
wall. In both the diffusion and reaction dominated cases, themajor-
ity of the arterial wall sees near uniform profiles formost of the per-
iod studied. In each of these cases, the one-dimensional model
provides a good approximation to the three-dimensional model,
especially at later times within the first 24 h. For the convection
dominated regime, there is a region close to the lumen where the
concentration profile is non-uniform. In this case the strut geome-
try has a large influence on the concentration profiles observed,
with high concentrations observed directly behind the struts and
a trough observed between struts. Consequently, the one-dimen-
sional model provides a less than ideal approximation to the
three-dimensional model. Generally speaking, the better the levels
Table 1
Updated results P1  P2k k and P11D  P13D



. This replaces Tables 4 and 5 of the original paper.
Regime 1 h (%) 3 h (%) 12 h (%) 24 h (%) 28 days (%)
P1  P2
Convection dominated 7.4 6.3 6.3 6.3 6.3
Diffusion dominated 5.8 3.7 3.5 3.5 3.5
Reaction dominated 7.2 5.5 5.4 5.4 5.4
P11D  P13D
Convection dominated 22.0 19.9 19.9 19.9 19.9
Diffusion dominated 12.8 7.4 6.6 6.6 6.6
Reaction dominated 13.4 9.6 9.3 9.3 9.3
Fig. 2. Updated results for the case of halved strut thickness and separation. Convection dominated regime. This replaces Fig. 7 of the original paper.
Table 2
Updated results for the case of halved strut thickness and separation. This replaces Table 6 of the original paper.
Regime 1 h (%) 3 h (%) 12 h (%) 24 h (%) 28 days (%)
P1  P2
Convection dominated 2.5 2.1 2.1 2.1 2.1
Diffusion dominated 2.5 1.7 1.7 1.7 1.7
Reaction dominated 3.0 2.3 .3 .3 .3
P11D  P13D
Convection dominated 15.2 13.5 13.5 13.5 13.5
Diffusion dominated 8.0 4.5 4.0 4.0 4.0
Reaction dominated 8.7 6.2 6.0 6.0 6.0
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replicating the results of the three-dimensional model. It is worth
emphasizing that the degree of variability of the estimates of the
parameters is substantially greater than the difference between
the one-dimensional and the three-dimensional model, lending
support to the hypothesis that, for themost part, a one-dimensional
model provides an adequate description of the diffusion process.It is interesting to assess our findings in the context of clinical
and manufacturing considerations. Clinicians suggest that uniform
drug concentration profiles are desirable. If it were the case that
drug distribution followed the pattern of the struts then large areas
of tissue would be exposed to levels of drug that would be ineffec-
tive while those areas directly behind the struts may receive toxic
levels of drug. From our analysis, we have shown that if uniform
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diffusion dominated transport would be desired. We have also
demonstrated that designing struts that are thinner and closer
together results in greater uniformity of drug concentrations more
quickly, resulting in better agreement between the one-dimen-
sional and three-dimensional models. Of course there are physio-
logical and mechanical constraints on how close together the
struts can be placed and on how thin they can be. Thus there is a
balance to be struck between reducing strut thickness and separa-
tion to ensure a uniform drug distribution and maintaining
mechanical integrity and sufficient tissue exposure to the lumen.
As we have already mentioned, many of the parameters in our
model are in fact drug-dependent. Bozsak et al. [15] studied the
transport properties of two commercial drugs, paclitaxel and siro-
limus, used to coat current drug-eluting stents. They found that
due to differences in the diffusion coefficients and binding param-
eters of these drugs, the main mechanism of transport was differ-
ent. They found that for paclitaxel the timescale for convection is
faster than that for drug binding while for sirolimus the timescale
for binding was faster than that for convection. Whilst it should be
stressed that [15] considered a more sophisticated model of bind-
ing, it is still, nonetheless, interesting to interpret their findings in
the context of this present work. If paclitaxel transport through the
arterial wall is indeed within the convection dominated regime,
then our results suggest that non-uniform drug concentrations
may be achieved close to the lumen for this drug, with the stent
strut geometry having a large influence on drug distribution. How-
ever, if sirolimus transport through the arterial wall is within the
reaction dominated regime then our results suggest more uniform
profiles, with the stent strut geometry having a smaller influence
on drug distribution close to the lumen. However, in both cases,
the majority of the arterial wall would see near-uniform concen-
tration profiles. This would suggest a one-dimensional modelmay more closely replicate the three-dimensional results of siroli-
mus transport through the arterial wall.
Our results have demonstrated that the higher the value of the
axial and circumferential diffusion coefficient, D1, with D1=DP 10,
the quicker the time taken for uniform drug concentrations to be
achieved in the abluminal-facing plane, and the better the compar-
ison between the one-dimensional and three-dimensional models.
Also, we have demonstrated that the greater the level of aniso-
tropy, i.e. the greater the value of D1=D, the more uniform the drug
concentrations are and the better the comparison between the
one-dimensional and three-dimensional models.
In summary, the least ideal situation from a clinical point of
view would appear to be the manufacturing of a device with thick
struts that are far apart and contain a drug that possesses slow
circumferential and axial diffusion coefficients of the same order
as the radial diffusion coefficient and satisfying Pe > 1. Under these
conditions, uniform drug concentrations would not be achieved
throughout the wall and this could result in regions of toxicity
and/or regions of under-exposure to therapeutic levels of drug. A
non-negligible area of highly non-uniform drug concentrations
would persist close to the lumen even after 24 h. For these reasons,
in this case the one-dimensional model would be a poor represen-
tation of the three-dimensional model. In contrast, the ideal situa-
tion from a drug delivery point of view would appear to be the
manufacturing of a device with thin struts that are close together,
containing a drug that possesses fast circumferential and axial
diffusion coefficients which are much larger than the radial diffu-
sion coefficient (D1=D 1Þ, and satisfy Pe < 1 and Da1 < 1. Under
these conditions, near-uniform drug concentrations would be
achieved quickly and would be transmitted through the arterial
wall. In this case the one-dimensional model would best replicate
the three-dimensional model.
